newsfilter
← Latest News
GlobeNewswire·

XBiotech Announces Successful Completion of Phase I portion of Pancreatic Cancer Study

AUSTIN, Texas, June 20, 2022 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today it successfully completed the Phase I portion of its 1-BETTER study, a Phase I/II randomized, double-blind, placebo-controlled clinical study to evaluate its a